Calcium channel blockade with nitrendipine. Effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans.
- 30 April 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 7 (3_Pt_1) , 438-442
- https://doi.org/10.1161/01.hyp.7.3_pt_1.438
Abstract
The antihypertensive effect of the calcium channel blocking drug nitrendipine may be in part related to natriuresis. Subjects (16, 8 normal, 8 hypertensive) were given placebo for 8 days followed by nitrendipine titrated to 20 mg twice daily for 8 days. The same diet was prepared for each meal for the entire study. Na intake was fixed for each subject and averaged 150 meq/day. All urine was collected every day. Blood was drawn at the end of the placebo and nitrendipine periods for renin, aldosterone, and norepinephrine values. Nitrendipine caused a significant increase (P < 0.05) in cumulative Na excretion of 161 meq over 7 days in the normal subjects and 103 meq in hypertensive subjects. K excretion was unaffected. In both hypertensive and normal subjects, plasma renin and plasma norepinephrine activity increased significantly (P < 0.05), while plasma aldosterone levels did not change. Upright systolic blood pressure decreased significantly (P < 0.05) in both groups, whereas upright diastolic blood pressure decreased only in hypertensive subjects. The blood pressure lowering effects of this drug may be in part related to natriuretics and that C channel blockade may dissociate plasma renin activity from that of aldosterone.This publication has 5 references indexed in Scilit:
- RENAL TUBULAR SITE OF ACTION OF FELODIPINE1984
- Calcium antagonists in hypertension: relation to abnormal sodium transport.BMJ, 1983
- Cellular Calcium MetabolismAnnals of Internal Medicine, 1983
- Role of a Natriuretic Factor in Essential Hypertension: An HypothesisAnnals of Internal Medicine, 1983
- Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertensionEuropean Journal of Clinical Pharmacology, 1979